ScholarX

Browsing by O'Reilly, EM[O'Reilly, Eileen Mary]Author

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
전체 가 나 다 라 마 바 사 아 자 차 카 타 파 하

Showing results 1 to 9 of 9

SCIESCOPUS
Adverse events (AEs) with maintenance olaparib in patients with a germline BRCA mutation (gBRCAm) and metastatic pancreatic cancer (mPaC): Phase III POLO trial

Reni, M[Reni, Michele]; Kindler, HL[Kindler, Hedy L.]; Hammel, P[Hammel, Pascal]; Van Cutsem, E[Van Cutsem, Eric]; Macarulla, T[Macarulla, Teresa]; Hall, MJ[Hall, Michael J.]; Park, JO[Park, Joon Oh]; Hochhauser, D[Hochhauser, Daniel]; Arnold, D[Arnold, Dirk]; Oh, DY[Oh, Do-Youn], et al.

ArticleIssue Date2020CitationJOURNAL OF CLINICAL ONCOLOGY, v.38, no.4PublisherAMER SOC CLINICAL ONCOLOGY
SCIESCOPUS
Early progression (progr) in patients (pts) with metastatic pancreatic cancer (mPaC) and a germline BRCA mutation (gBRCAm): Phase III POLO trial of olaparib (O) versus placebo (P)

Macarulla, T[Macarulla, Teresa]; Kindler, HL[Kindler, Hedy L.]; Hammel, P[Hammel, Pascal]; Reni, M[Reni, Michele]; Van Cutsem, E[Van Cutsem, Eric]; Hall, MJ[Hall, Michael J.]; Park, JO[Park, Joon Oh]; Hochhauser, D[Hochhauser, Daniel]; Arnold, D[Arnold, Dirk]; Oh, DY[Oh, Do-Youn], et al.

ArticleIssue Date2020CitationJOURNAL OF CLINICAL ONCOLOGY, v.38, no.4PublisherAMER SOC CLINICAL ONCOLOGY
SCIESCOPUS
Evaluation of microsatellite instability status, a definitive predictive biomarker for immune checkpoint inhibitors (ICI), in underrepresented minorities (URM) with gastrointestinal (GI) cancers

Balogun, F[Balogun, Fiyinfolu]; Altoe, M[Altoe, Mirella]; O'Connor, C[O'Connor, Catherine]; Chowdhury, N[Chowdhury, Nobel]; Cercek, A[Cercek, Andrea]; Lee, CK[Lee, Choong-kun]; Foote, MB[Foote, Michael Bonner]; Kim, D[Kim, Daehee]; Maron, SB[Maron, Steven Brad]; Kim, DW[Kim, Dae Won], et al.

ArticleIssue Date2023CitationJOURNAL OF CLINICAL ONCOLOGY, v.41, no.16PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Olaparib as maintenance treatment following first-line platinum-based chemotherapy (PBC) in patients (pts) with a germline BRCA mutation and metastatic pancreatic cancer (mPC): Phase III POLO trial.

Kindler, HL[Kindler, Hedy L.]; Hammel, P[Hammel, Pascal]; Reni, M[Reni, Michele]; Van Cutsem, E[Van Cutsem, Eric]; Macarulla, T[Macarulla, Teresa]; Hall, MMJ[Hall, Mercade Michael J.]; Park, JO[Park, Joon Oh]; Hochhauser, D[Hochhauser, Daniel]; Arnold, D[Arnold, Dirk]; Oh, DY[Oh, Do-Youn], et al.

ArticleIssue Date2019CitationJOURNAL OF CLINICAL ONCOLOGY, v.37, no.18PublisherAMER SOC CLINICAL ONCOLOGY
SCIESCOPUS
Overall survival from the phase 3 POLO trial: Maintenance olaparib for germline BRCA-mutated metastatic pancreatic cancer.

Golan, T[Golan, Talia]; Hammel, P[Hammel, Pascal]; Reni, M[Reni, Michele]; Van Cutsem, E[Van Cutsem, Eric]; Macarulla, T[Macarulla, Teresa]; Hall, MJ[Hall, Michael J.]; Park, JO[Park, Joon Oh]; Hochhauser, D[Hochhauser, Daniel]; Arnold, D[Arnold, Dirk]; Oh, DY[Oh, Do-Youn], et al.

ArticleIssue Date2021CitationJOURNAL OF CLINICAL ONCOLOGY, v.39, no.3PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Pancreatic cancer (PaC)-specific health-related quality of life (HRQoL) with maintenance olaparib (O) in patients (pts) with metastatic (m) PaC and a germline BRCA mutation (gBRCAm): Phase III POLO trial

Hall, MJ[Hall, Michael J.]; Golan, T[Golan, Talia]; Hammel, P[Hammel, Pascal]; Reni, M[Reni, Michele]; Van Cutsem, E[Van Cutsem, Eric]; Macarulla, T[Macarulla, Teresa]; Park, JO[Park, Joon Oh]; Hochhauser, D[Hochhauser, Daniel]; Arnold, D[Arnold, Dirk]; Oh, DY[Oh, Do-Youn], et al.

ArticleIssue Date2020CitationJOURNAL OF CLINICAL ONCOLOGY, v.38, no.4PublisherAMER SOC CLINICAL ONCOLOGY
SCIESCOPUS
Phase III APACT trial of adjuvant nab-paclitaxel plus gemcitabine (nab-P plus Gem) versus gemcitabine (Gem) alone for patients with resected pancreatic cancer (PC): Outcomes by geographic region.

Reni, M[Reni, Michele]; Riess, H[Riess, Hanno]; O'Reilly, EM[O'Reilly, Eileen Mary]; Park, JO[Park, Joon Oh]; Hatoum, H[Hatoum, Hassan]; Saez, BL[Saez, Berta Laquente]; Salminen, T[Salminen, Tapio]; Oettle, H[Oettle, Helmut]; Lopez, R[Lopez, Rafael]; Dowden, SD[Dowden, Scot D.], et al.

ArticleIssue Date2020CitationJOURNAL OF CLINICAL ONCOLOGY, v.38, no.15PublisherAMER SOC CLINICAL ONCOLOGY
SCIESCOPUS
POLO: Radiologic assessment of the impact of maintenance olaparib in patients (pts) with metastatic pancreatic cancer (mPaC).

Schwartz, LH[Schwartz, Lawrence Howard]; Kindler, HL[Kindler, Hedy L.]; Hammel, P[Hammel, Pascal]; Reni, M[Reni, Michele]; Van Cutsem, E[Van Cutsem, Eric]; Macarulla, T[Macarulla, Teresa]; Hall, MJ[Hall, Michael J.]; Park, JO[Park, Joon Oh]; Hochhauser, D[Hochhauser, Daniel]; Arnold, D[Arnold, Dirk], et al.

ArticleIssue Date2021CitationJOURNAL OF CLINICAL ONCOLOGY, v.39, no.3PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
POLO: Radiologic assessment of the impact of maintenance olaparib in patients (pts) with metastatic pancreatic cancer (mPaC).

Schwartz, LH[Schwartz, Lawrence Howard]; Kindler, HL[Kindler, Hedy L.]; Hammel, P[Hammel, Pascal]; Reni, M[Reni, Michele]; Van Cutsem, E[Van Cutsem, Eric]; Macarulla, T[Macarulla, Teresa]; Hall, MJ[Hall, Michael J.]; Park, JO[Park, Joon Oh]; Hochhauser, D[Hochhauser, Daniel]; Arnold, D[Arnold, Dirk], et al.

ArticleIssue Date2020CitationJOURNAL OF CLINICAL ONCOLOGY, v.38, no.15PublisherLIPPINCOTT WILLIAMS & WILKINS
1
STATISTICS
Total View:
Daily View:

RSS_1.0 RSS_2.0 ATOM_1.0

CONTACT US

(03063) 25-2, SUNGKYUNKWAN-RO, JONGNO-GU, SEOUL, KOREA samsunglib@skku.edu

COPYRIGHT © 2021 SUNGKYUNKWAN UNIVERSITY ALL RIGHTS RESERVED.

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

BROWSE

한국어